TWP
GILD icon

Triad Wealth Partners’s Gilead Sciences GILD Stock Holding History

Triad Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$517K Buy
3,712
+211
+6% +$29.5K 0.04% 271
2025
Q4 		$430K Buy
3,501
+1,192
+52% +$145K 0.04% 299
2025
Q3 		$256K Buy
2,309
+462
+25% +$52.5K 0.03% 318
2025
Q2 		$205K Buy
+1,847
New +$197K 0.04% 285
2024
Q3 		– Sell
-922
Closed -$63.3K – 374
2024
Q2 		$63.3K Buy
+922
New +$61.5K 0.03% 193

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Triad Wealth Partners's GILD Position: Q1 2026 in Review

Triad Wealth Partners increased its Gilead Sciences (GILD) stake by 6% in Q1 2026, buying an estimated $29.5K and bringing the position to 3,712 shares worth $517K. The position accounts for 0.04% of the portfolio, ranked #271.

Triad Wealth Partners first reported a position in GILD in Q2 2024 and has held it in 5 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Triad Wealth Partners held 3,712 shares of Gilead Sciences worth $517K as of Q1 2026.
  • Triad Wealth Partners bought 211 Gilead Sciences shares in Q1 2026, an estimated $29.5K.
  • Gilead Sciences made up 0.04% of Triad Wealth Partners's portfolio in Q1 2026, its #271 holding.
  • Triad Wealth Partners first reported a position in Gilead Sciences in Q2 2024 and has held it in 5 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.